ELOCP18

Across TCGA pan-cancer cohorts, ELOCP18 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of ELOCP18’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where ELOCP18 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ELOCP18 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

HNSC, KIRC, and LUSC are the cancer types where ELOCP18 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ELOCP18 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.064	.004	6	view →
KIRC	Male	II,III,IV	−0.023	.021	4	view →
LUSC	All	All	+0.050	.017	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

ELOCP18–HNSC

Open the HNSC breakdown →